191 related articles for article (PubMed ID: 23091827)
41. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
Escobar C; Barrios V; Jimenez D
Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
[TBL] [Abstract][Full Text] [Related]
42. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
43. [Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
Shevelev VI; Kanorsky SG
Klin Med (Mosk); 2012; 90(10):60-3. PubMed ID: 23285766
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
[TBL] [Abstract][Full Text] [Related]
45. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
46. A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation.
Snipelisky D; Ray JC; Ung R; Duart M; Kauffman C; Kusumoto F
J Interv Card Electrophysiol; 2014 Dec; 41(3):231-6. PubMed ID: 25380703
[TBL] [Abstract][Full Text] [Related]
47. Learning the respective roles of warfarin and dabigatran to prevent stroke in patients with nonvalvular atrial fibrillation.
Beyth RJ; Landefeld CS
Ann Intern Med; 2011 Nov; 155(10):714-5, W218. PubMed ID: 22084336
[No Abstract] [Full Text] [Related]
48. [Atrial fibrillation: what the GP needs to know].
Diener HC; Kaeufer T; Bode C
MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
[No Abstract] [Full Text] [Related]
49. [Wünderlich syndrome in patient anticoagulated with dabigatran].
de Gea-García JH; Alvarez M; Ruiz-Villa G; Jiménez-Parra JD
Med Clin (Barc); 2013 Aug; 141(4):184-5. PubMed ID: 23369498
[No Abstract] [Full Text] [Related]
50. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.
González-Juanatey JR; Álvarez-Sabin J; Lobos JM; Martínez-Rubio A; Reverter JC; Oyagüez I; González-Rojas N; Becerra V
Rev Esp Cardiol (Engl Ed); 2012 Oct; 65(10):901-10. PubMed ID: 22958943
[TBL] [Abstract][Full Text] [Related]
52. [Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure].
Zeus T; Kelm M; Bode C
Dtsch Med Wochenschr; 2015 Aug; 140(16):1213-5. PubMed ID: 26261929
[TBL] [Abstract][Full Text] [Related]
53. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
Brem E; Koyfman A; Foran M
J Emerg Med; 2013 Jul; 45(1):143-9. PubMed ID: 23375217
[TBL] [Abstract][Full Text] [Related]
54. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
Albert NM
Heart Lung; 2014; 43(1):48-59. PubMed ID: 24373340
[TBL] [Abstract][Full Text] [Related]
55. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
Brunetti L; Chen C; White J
Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
[TBL] [Abstract][Full Text] [Related]
56. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
57. The importance of postapproval data for dabigatran.
Redberg RF
JAMA Intern Med; 2015 Jan; 175(1):25. PubMed ID: 25365377
[No Abstract] [Full Text] [Related]
58. Modeling of the impact on health outcomes of the use of dabigatran in patients with atrial fibrillation.
Chevalier J; Giroud M; de Pouvourville G
Cerebrovasc Dis; 2013; 35(4):320-6. PubMed ID: 23615428
[TBL] [Abstract][Full Text] [Related]
59. New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.
Barrios V; Escobar C
Expert Opin Pharmacother; 2012 Dec; 13(18):2649-61. PubMed ID: 23167273
[TBL] [Abstract][Full Text] [Related]
60. New oral anticoagulants in heart failure.
Van Gelder IC; Van Veldhuisen DJ; Lip GY
Eur J Heart Fail; 2013 Sep; 15(9):966-73. PubMed ID: 23960085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
